Addus HomeCare Corporation
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Addus HomeCare Corporation.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 88.50 $ to 122.80 $ · Last price: 117.10 $ (As of: September 18, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Medical Care Facilities
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Addus HomeCare Corporation ADUS | 2.2 | 22.1 | 13.0 | 32.0 | 9.4 | 23.2 | 9.2 |
| HCA Healthcare, Inc. HCA | 94.9 | 15.2 | 9.0 | 42.6 | 15.0 | 7.1 | 7.4 |
| Tenet Healthcare Corporation THC | 22.6 | 14.0 | 5.8 | 41.7 | 17.9 | 3.1 | 42.8 |
| Encompass Health Corp EHC | 12.1 | 21.1 | 9.8 | 43.9 | 19.0 | 10.5 | -0.2 |
| DaVita HealthCare Partners Inc DVA | 11.7 | 18.2 | 8.9 | 32.4 | 13.9 | 6.5 | 43.0 |
| Universal Health Services Inc UHS | 10.7 | 7.7 | 5.5 | 44.6 | 11.2 | 9.7 | -3.1 |
| The Ensign Group Inc ENSG | 10.2 | 29.1 | 19.3 | 16.6 | 9.0 | 18.7 | 5.6 |
| Chemed Corp CHE | 6.7 | 29.7 | 15.7 | 33.1 | 12.9 | 4.1 | 11.2 |
| PACS Group, Inc. PACS | 6.5 | – | 20.3 | 17.3 | 8.5 | 29.3 | 274.9 |
| Median of companies shown | 10.7 | 19.6 | 9.8 | 33.1 | 12.9 | 9.7 | 9.2 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 401 | 15 | 12 | 1.04 | -1 | 159 | 231 |
| 2017 | 426 | 25 | 14 | 1.17 | 53 | 176 | 267 |
| 2018 | 518 | 23 | 18 | 1.33 | 33 | 276 | 355 |
| 2019 | 649 | 35 | 25 | 1.62 | 12 | 476 | 637 |
| 2020 | 765 | 45 | 33 | 2.08 | 109 | 519 | 893 |
| 2021 | 865 | 66 | 45 | 2.81 | 39 | 574 | 948 |
| 2022 | 951 | 69 | 46 | 2.84 | 105 | 634 | 938 |
| 2023 | 1,059 | 91 | 63 | 3.83 | 112 | 707 | 1,024 |
| 2024 | 1,155 | 103 | 74 | 4.23 | 116 | 970 | 1,413 |
| 2025 | 1,423 | 139 | 96 | 5.20 | 112 | 1,085 | 1,437 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.07 | -11.10 | 297 | 7.50 | 6.60 | 10 | 9 |
| 2025: Q1 | 1.15 | 19.30 | 338 | 20.30 | 6.30 | 19 | 17 |
| 2025: Q2 | 1.20 | 9.70 | 349 | 21.80 | 6.30 | 23 | 21 |
| 2025: Q3 | 1.24 | 12.60 | 362 | 25.00 | 6.30 | 51 | 49 |
| 2025: Q4 | 1.61 | 51.30 | 373 | 25.60 | 8.00 | 19 | 16 |
| 2026: Q1 | 1.36 | 17.50 | 364 | 7.70 | 6.90 | 52 | 51 |
| 2026: Q2 | 1.49 | 24.20 | 377 | 8.00 | 7.30 | 40 | 39 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Quality & Balance Sheet
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 7.05 | 6.96 – 7.14 | 1,524 | 13.1% | 14 |
| 12/31/2027 | 7.51 | 7.29 – 7.67 | 1,598 | 6.6% | 14 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 3.1% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $153.1M |
|---|---|
| Market cap | $2.18B |
| Free cash flow in year ten | $207.2M |
| Terminal value as a share of market value | 50.1% |
For comparison: over the past five years free cash flow grew by 0.2% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 14.4%
- More than 10% revenue growth is expected for the coming year 4.8%
- Share count grows by less than 3% a year 4.5%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 30.5%
- Gross margin at 40% or higher and without meaningful erosion 32.5%
- Goodwill from acquisitions does not grow faster than revenue 69.3%
- Net debt below twice EBITDA 0.8 x EBITDA
- Operating cash flow covers the profits of the last three years 108 m
- Return on capital at 15% or higher, or up versus two years ago 10.8%
- Insiders hold at least 10% or are net buyers 2.8%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
8/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 15.1%
- Exp. sales growth 3Y > 5% 6.0%
- EBIT growth 10Y > 5% 27.6%
- Exp. EBIT growth 3Y > 5% 20.2%
- Net debt < 4x EBIT 0.9x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 9.6%
- Return on equity > 15% –
- ROCE > 15% 10.8%
- Expected return > 10% 25.9%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | Cliff Donald Blessing | EVP | Sell | 178 | 93.61 | 16,663 |
The company
About the Company
Addus HomeCare Corporation bietet gemeinsam mit ihren Tochtergesellschaften Körperpflegedienste für ältere, chronisch kranke und behinderte Menschen sowie Personen mit Hospitalisierungs- oder Institutionalisierungsrisiko in den USA an. Das Unternehmen ist in drei Segmenten tätig: Personal Care,…
- Employees
- 5,982
- Headquarters
- Frisco, TX
- Address
- 6303 Cowboys Way, 75034 Frisco, United States
- Phone
- 469 535 8200
- Website
- addus.com
- IPO Date
- 10/28/2009
- ISIN
- US0067391062
Management
| Name | Title | Birth Year |
|---|---|---|
| R. Dirk Allison CPA | CEO & Chairman of the Board | 1956 |
| Brian W. Poff | CFO, Executive VP, Secretary & Treasurer | 1974 |
| W. Bradley Bickham J.D. | Interim Chief Operating Officer | 1963 |
| Sean P. Gaffney J.D. | Executive VP & Chief Legal Officer | 1980 |
| Darby Anderson | Executive VP & Chief Government Relations Officer | 1966 |
| Zach Simpson | Senior VP & Chief Accounting Officer | – |
| Michael D. Wattenbarger | Executive VP & Chief Information Officer | 1971 |
| Monica Raines J.D. | Executive VP and Chief Compliance & Quality Officer | 1980 |
| Roberton James Stevenson | Executive VP & Chief Human Resource Officer | 1981 |
| Diane Kumarich | Senior Vice President of Payor Innovation | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 09/14/2026 Addus HomeCare Corp (ADUS): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
- 08/13/2026 Addus HomeCare Corp (ADUS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
- 08/03/2026 Addus HomeCare Corp (ADUS): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.